Harrow, Inc. Gain (Loss) on Extinguishment of Debt
Harrow, Inc. (HROW) reported Gain (Loss) on Extinguishment of Debt of -$7.75 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-03-02
- Harrow, Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-12-31 was $0.00.
- Harrow, Inc. gain (loss) on extinguishment of debt for the quarter ending 2025-09-30 was -$7.75M.
- Harrow, Inc. gain (loss) on extinguishment of debt for the quarter ending 2023-12-31 was $0.00.
- Harrow, Inc. gain (loss) on extinguishment of debt for the quarter ending 2023-09-30 was $0.00.
- Harrow, Inc. gain (loss) on extinguishment of debt for fiscal 2025 was -$7.75M.
- Harrow, Inc. gain (loss) on extinguishment of debt for fiscal 2023 was -$5.46M.
- Harrow, Inc. gain (loss) on extinguishment of debt for fiscal 2017 was $884.00K.
- Harrow, Inc. gain (loss) on extinguishment of debt for fiscal 2016 was -$1.97M.
| Period end | Gain (Loss) on Extinguishment of Debt 0 month | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 9 month as first filed | Gain (Loss) on Extinguishment of Debt 12 month | Gain (Loss) on Extinguishment of Debt 12 month as first filed | Gain (Loss) on Extinguishment of Debt 155 month | Gain (Loss) on Extinguishment of Debt 158 month | Gain (Loss) on Extinguishment of Debt 161 month | Gain (Loss) on Extinguishment of Debt 164 month | Gain (Loss) on Extinguishment of Debt 167 month | Gain (Loss) on Extinguishment of Debt 170 month | Gain (Loss) on Extinguishment of Debt 173 month | Gain (Loss) on Extinguishment of Debt 176 month | Gain (Loss) on Extinguishment of Debt 182 month | Gain (Loss) on Extinguishment of Debt 185 month | Gain (Loss) on Extinguishment of Debt 188 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$7.75M derived: sum of 2 quarters · filed 2026-03-02 | -$7.75M 10-K · filed 2026-03-02 | |||||||||||||||
| 2025-09-30 | -$7.75M 10-Q · filed 2025-11-10 | -$7.75M 10-Q · filed 2025-11-10 | ||||||||||||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $0.00 derived: sum of 2 quarters · filed 2026-03-02 | -$5.46M 10-K · filed 2026-03-02 | |||||||||||||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$5.46M 10-Q · filed 2024-11-14 | ||||||||||||||||
| 2023-06-30 | -$5.46M 10-Q · filed 2024-08-07 | |||||||||||||||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$706.00K 10-Q · filed 2021-11-09 | ||||||||||||||||
| 2021-06-30 | -$706.00K 10-Q · filed 2021-08-10 | |||||||||||||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$884.00K derived: sum of 2 quarters · filed 2019-03-12 | $884.00K 10-K · filed 2019-03-12 | -$884.00K 10-K · filed 2018-03-08 | ||||||||||||||
| 2017-09-30 | -$884.00K 10-Q · filed 2017-11-14 | $884.00K 10-Q · filed 2018-11-13 | -$884.00K 10-Q · filed 2017-11-14 | |||||||||||||||
| 2016-12-31 | -$1.97M 10-K · filed 2018-03-08 | |||||||||||||||||
| 2014-03-31 | -$1.20M 10-Q · filed 2014-05-15 | |||||||||||||||||
| 2013-12-31 | -$1.20M 10-K · filed 2014-03-28 | |||||||||||||||||
| 2013-09-30 | -$1.20M 10-Q · filed 2013-11-06 | |||||||||||||||||
| 2013-06-30 | -$1.20M 10-Q · filed 2013-08-14 | |||||||||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-08 | $0.00 derived: sum of 2 quarters · filed 2014-03-28 | $0.00 derived: sum of 3 quarters · filed 2014-03-28 | -$189.32K derived: sum of 4 quarters · filed 2014-03-28 | -$1.20M 10-Q · filed 2013-05-08 | |||||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $0.00 derived: sum of 2 quarters · filed 2014-03-28 | -$189.32K derived: sum of 3 quarters · filed 2014-03-28 | -$1.20M 10-K · filed 2014-03-28 | -$1.20M 10-K · filed 2013-03-18 | |||||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | -$189.32K derived: sum of 2 quarters · filed 2013-11-06 | -$1.20M 10-Q · filed 2013-11-06 | -$1.20M derived: sum of 4 quarters · filed 2013-11-06 | -$1.20M 10-Q · filed 2012-11-14 | |||||||||||||
| 2012-06-30 | -$189.32K 10-Q · filed 2013-08-14 | -$1.20M 10-Q · filed 2013-08-14 | -$1.20M derived: sum of 3 quarters · filed 2013-08-14 | -$1.20M derived: sum of 4 quarters · filed 2013-08-14 | -$1.20M 10-Q · filed 2012-08-14 | |||||||||||||
| 2012-04-20 | $189.32K 10-K · filed 2014-03-28 | |||||||||||||||||
| 2012-03-31 | -$1.01M 10-Q · filed 2013-05-08 | -$1.01M derived: sum of 2 quarters · filed 2013-05-08 | -$1.01M derived: sum of 3 quarters · filed 2013-05-08 | -$1.01M derived: sum of 4 quarters · filed 2013-05-08 | -$1.01M 10-Q · filed 2012-05-10 | |||||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $0.00 derived: sum of 2 quarters · filed 2013-03-18 | $0.00 derived: sum of 3 quarters · filed 2013-03-18 | $0.00 10-K · filed 2013-03-18 | $60.29K 10-K · filed 2012-02-23 | $176.50K 10-K · filed 2012-02-23 | ||||||||||||
| 2011-09-30 | $0.00 10-Q · filed 2012-02-23 | $0.00 derived: sum of 2 quarters · filed 2012-02-23 | $0.00 10-Q · filed 2012-02-23 | $0.00 derived: sum of 4 quarters · filed 2012-05-10 | $116.21K 10-Q · filed 2012-02-23 | |||||||||||||
| 2011-06-30 | $0.00 10-Q · filed 2012-02-23 | $0.00 10-Q · filed 2012-02-23 | $0.00 derived: sum of 3 quarters · filed 2012-05-10 | $0.00 derived: sum of 4 quarters · filed 2012-05-10 | $116.21K 10-Q · filed 2012-02-23 | |||||||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-10 | $0.00 derived: sum of 2 quarters · filed 2012-05-10 | $0.00 derived: sum of 3 quarters · filed 2012-05-10 | $26.30K derived: sum of 4 quarters · filed 2012-05-10 | ||||||||||||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $0.00 derived: sum of 2 quarters · filed 2012-02-23 | $26.30K derived: sum of 3 quarters · filed 2012-02-23 | $26.30K 10-K · filed 2012-02-23 | ||||||||||||||
| 2010-09-30 | $0.00 10-Q · filed 2012-02-23 | $26.30K derived: sum of 2 quarters · filed 2012-02-23 | $26.30K 10-Q · filed 2012-02-23 | |||||||||||||||
| 2010-06-30 | $26.30K 10-Q · filed 2012-02-23 | $26.30K 10-Q · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |